Abstract
This chapter provides a practical approach to the diagnosis and management of the most common types of primary cicatricial alopecias. In primary scarring alopecias, the target of the inflammation is the hair follicle. In secondary scarring alopecias, the hair follicle is an innocent bystander in the disease process and is destroyed in a nonspecific manner. Examples of secondary scarring alopecias include deep burns, radiation dermatitis, cutaneous malignancies, cutaneous sarcoidosis, morphea, necrobiosis lipoidica, and certain chronic infections such as cutaneous tuberculosis. Secondary forms of scarring hair loss are quite common and must be considered in the differential diagnosis of late-stage primary scarring hair loss when inflammatory clues are no longer available to help with diagnosis. The diagnostic hallmark of all forms of cicatricial alopecia (primary and secondary) is visible loss of follicular ostia. In this chapter, we will focus on helpful clinical clues that help distinguish the various primary scarring alopecias and allow distinction from potentially similar non-scarring alopecias. Treatments will be discussed based on the inflammatory level of typical pathologic examination of each entity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sperling L, et al. Alopecias. In: Bolognia J, Jorizzo JL, Rapini RP, editors. Dermatology. St. Louis, MO: Elsevier; 2008. p. 996.
Finner AM, Otberg N, Shapiro J. Secondary cicatricial and other permanent alopecias. Dermatol Ther. 2008;21(4):279–94.
Olsen EA, Bergfeld WF, Cotsarelis G, et al. Summary of North American hair research society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol. 2003;48(1):103–10.
Sperling LC. Scarring alopecia and the dermatopathologist. J Cutan Pathol. 2001;28(7): 333–42.
Sperling LC, Skelton 3rd HG, Smith KJ, Sau P, Friedman K. Follicular degeneration syndrome in men. Arch Dermatol. 1994;130(6):763–9.
Sperling LC, Sau P. The follicular degeneration syndrome in black patients. “Hot comb alopecia” revisited and revised. Arch Dermatol. 1992;128(1):68–74.
LoPresti P, Papa CM, Kligman AM. Hot comb alopecia. Arch Dermatol. 1968;98(3):234–8.
McMichael AJ. Ethnic hair update: past and present. J Am Acad Dermatol. 2003;48(6 Suppl):S127–33.
Nnoruka EN. Hair loss: is there a relationship with hair care practices in Nigeria? Int J Dermatol. 2005;44 Suppl 1:13–7.
McMichael AJ. Hair and scalp disorders in ethnic populations. Dermatol Clin. 2003;21(4): 629–44.
Bulengo-Ransby SM, Bergfeld WF. Chemical and traumatic alopecia from thioglycolate in a black woman: a case report with unusual clinical and histologic findings. Cutis. 1992;49(2): 99–103.
Gathers RC, Jankowski M, Eide M, Lim HW. Hair grooming practices and central centrifugal cicatricial alopecia. J Am Acad Dermatol. 2009;60(4):574–8.
Martin ES, Elewski BE. Tinea capitis in adult women masquerading as bacterial pyoderma. J Am Acad Dermatol. 2003;49(2 Suppl Case Reports):S177–9.
Sperling LC, Solomon AR, Whiting DA. A new look at scarring alopecia. Arch Dermatol. 2000;136(2):235–42.
Ackerman AB, Walton NW, Jones RE, Charissi C. “Hot comb alopecia”/ “Follicular degeneration syndrome” in African American women is traction alopecia. Dermatopath: Practical Conceptual. 2000;6:6–21.
Olsen EA. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective. j investig dermatol Symp proc. 2005;10(3):217–21.
Scott DA. Disorders of the hair and scalp in blacks. Dermatol Clin. 1988;6(3):387–95.
Price VH. The medical treatment of cicatricial alopecia. Semin Cutan Med Surg. 2006;25(1):56–9.
Taylor S. Practical tips for managing hair disorders in African-American females. Pract Dermatol. 2006;3(7):25–7.
Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol Ther. 2004;17(2):164–76.
Brown MD, Johnson T, Swanson NA. Extensive keloids following hair transplantation. J Dermatol Surg Oncol. 1990;16(9):867–9.
Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42(5):342–5.
Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27(6 Pt 1):935–42.
Mirmirani P. Cicatricial Alopecia. In: healthcare I, editor. Hair and scalp diseases: medical, surgical and cosmetic treatments. New York: Informa Healthcare; 2008. p. 137–48.
Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol. 1997;36(1):59–66.
Zinkernagel MS, Trueb RM. Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch Dermatol. 2000;136(2):205–11.
Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S. Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol. 2001;26(6).
Amato L, Mei S, Massi D, Gallerani I, Fabbri P. Cicatricial alopecia; a dermatopathologic and immunopathologic study of 33 patients (pseudopelade of Brocq is not a specific clinico-pathologic entity). Int J Dermatol. 2002;41(1):8–15.
Silvers DN, Katz BE, Young AW. Pseudopelade of Brocq is lichen planopilaris: report of four cases that support this nosology. Cutis. 1993;51(2):99–105.
Ronchese F. Pseudopelade. Arch dermat. 1960;82:336–43.
Karnik P, Tekeste Z, McCormick TS, et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol. 2009;129(5):1243–57.
Harries MJ, Paus R. Scarring alopecia and the PPAR-gamma connection. J Invest Dermatol. 2009;129(5):1066–70.
Otberg N, Wu WY, McElwee KJ, Shapiro J. Diagnosis and management of primary cicatricial alopecia: part I. Skinmed. 2008;7(1):19–26.
Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case-series of 29 patients with lichen planopilaris: the Cleveland clinic foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57(1):47–53.
George YA RS, Gottlieb J, et al. Betamethasone valerate 0.12 % in foam vehicle scalp dermatitis in African Americans. Cosmet Dermatol. 2002;15:23–7.
Callen JP K-SC, Wolverton SE. Methotrexate. In: Comprehensive dermatologic drug therapy. Seconth ed. Philadelphia: Saunders; 2007.
Turan H, Baskan EB, Tunali S, Yazici S, Saricaoglu H. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol. 2009;60(1):164–6.
Nylander Lundqvist E, Wahlin YB, Hofer PA. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen ruber. Acta Derm Venereol. 2002;82(1):63–4.
Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49(4):667–71.
Bohm M, Beissert S, Schwarz T, Metze D, Luger T. Bullous pemphigoid treated with mycophenolate mofetil. Lancet. 1997;349(9051):541.
Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet. 1997;350(9076):494.
Frieling U, Bonsmann G, Schwarz T, Luger TA, Beissert S. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003;49(6):1063–6.
Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005;52(1):55–60.
George SJ, Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol. 2001;45(6):965–6.
Callen JP. Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol. 1982;118(6):412–6.
McCarty DJ, Manzi S, Medsger Jr TA, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995;38(9):1260–70.
Tebbe B, Mansmann U, Wollina U, et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol. 1997;77(4): 305–8.
Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol. 1992;128(3):368–71.
Headington JT. Cicatricial alopecia. Dermatol Clin. 1996;14(4):773–82.
Koca R, Altinyazar HC, Ozen OI, Tekin NS. Dissecting cellulitis in a white male: response to isotretinoin. Int J Dermatol. 2002;41(8):509–13.
Sukhatme SV, Lenzy YM, Gottlieb AB. Refractory dissecting cellulitis of the scalp treated with adalimumab. J Drugs Dermatol. 2008;7(10):981–3.
Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol. 1996;134(6):1105–8.
Williams CN, Cohen M, Ronan SG, Lewandowski CA. Dissecting cellulitis of the scalp. Plast Reconstr Surg. 1986;77(3):378–82.
Brandt HR, Malheiros AP, Teixeira MG, Machado MC. Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab. Br J Dermatol. 2008;159(2):506–7.
Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges. 2008;6(1):44–7.
Georgala S, Korfitis C, Ioannidou D, Alestas T, Kylafis G, Georgala C. Dissecting cellulitis of the scalp treated with rifampicin and isotretinoin: case reports. Cutis. 2008;82(3):195–8.
Glass LF, Berman B, Laub D. Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol. 1989;15(6):673–6.
Boyd AS, Binhlam JQ. Use of an 800-nm pulsed-diode laser in the treatment of recalcitrant dissecting cellulitis of the scalp. Arch Dermatol. 2002;138(10):1291–3.
Chui CT, Berger TG, Price VH, Zachary CB. Recalcitrant scarring follicular disorders treated by laser-assisted hair removal: a preliminary report. Dermatol Surg. 1999;25(1):34–7.
Krasner BD, Hamzavi FH, Murakawa GJ, Hamzavi IH. Dissecting cellulitis treated with the long-pulsed Nd:YAG laser. Dermatol Surg. 2006;32(8):1039–44.
Wu WY, Otberg N, McElwee KJ, Shapiro J. Diagnosis and management of primary cicatricial alopecia: part II. Skinmed. 2008;7(2):78–83.
Powell JJ, Dawber RP, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol. 1999;140(2):328–33.
Powell J, Dawber RP. Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia. Arch Dermatol. 2001;137(3):373–4.
Abeck D, Korting HC, Braun-Falco O. Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol. 1992;72(2):143–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lenzy, Y.M., McMichael, A.J. (2013). Cicatricial Alopecias. In: Alexis, A., Barbosa, V. (eds) Skin of Color. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84929-4_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-84929-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84928-7
Online ISBN: 978-0-387-84929-4
eBook Packages: MedicineMedicine (R0)